化学药物杂质研究技术指导原则.pdf

《化学药物杂质研究技术指导原则.pdf》由会员上传分享，免费在线阅读，更多相关内容在教育资源-天天文库。

1、指导原则编号：【H】GPH3-1化学药物杂质研究的技术指导原则二○○五年三月目录一、概述·····················································································································································1二、杂质的分类·····················································

2、···············································································2三、分析方法·········································································································································3(一)分析方法的选择····················

3、·······································································································31、有机杂质的分析方法············································································································32、无机杂质的分析方法···················

4、·························································································3(二)分析方法的验证···························································································································5(三)有机杂质的定量方法··················

5、······························································································6四、杂质检测数据的积累··············································································································7五、杂质限度的制订····························

6、································································································9(一)有机杂质的限度确定·············································································································101、创新药物····························

7、··········································································································102、仿制已有国家标准的药品································································································123、其它新药·····························

8、········································································································12(二)无机杂质的限度确定········································································································